Serum transforming growth factor-β1 level reflects disease status in patients with esophageal carcinoma after radiotherapy

Table 4 Characteristics of ten patients

Case	Location	Stage	Response to RT	Failure or metastasis	TGFβ1 (ng/mL)
					Before	After
1	Upper	III	NC	Lymph nodes M	30.10	42.80
2	Middle	IIb	NC	Lymph nodes M	51.95	67.65
3	Upper	IIa	PR	Lymph nodes M	18.60	38.20
4	Upper	III	PR	Lymph nodes and bone M	25.93	28.73
5	Middle	III	PR	Trachea M	29.45	29.55
6	Lower	IIa	PR	Regional failure	23.05	27.18
7	Middle	IIa	PR	Regional failure	40.68	19.88
8	Middle	IIb	PR	Regional failure	30.08	62.65
9	Upper	I	CR	Regional failure	40.73	49.03
10	Upper	I	PR	Lymph nodes M	13.00	32.65